Creative Biolabs-Immuno-oncology

Anti-CCP (clone F1G2E) SynExpress E1-Cy3-TF2-X Modified CD8+ T cells (CAT#: ITS-1224-CR312)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCP (clone F1G2E). We employs the Adenovirus (EF1α-Cy3-TFIIB-XbaI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Balancing feedback for a robust and sustained response against cancers.
Host
human
Target
CCP
Clone
F1G2E
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
EF1α
Effector Gene
TFIIB
Insertion Sites
XbaI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
Adenovirus
Transformation Accuracy
0.86
Cell Culture
Plate Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving